Annalise Enterprise Radiology AI Solutions
Annalise.ai · Operations & Productivity
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 7 captures on record
What the publisher says
As described on Microsoft Marketplace.
Annalise.ai develops comprehensive AI products in Radiology (Chest X-ray, Non Contrast CT Brain) that seamlessly integrate with the physician’s workflow and the organization's IT systems.
Our products can help (a) triage studies, (b) assist a clinician while reporting a study and (c) automatically draft a preliminary report for sign off by a clinician.
Show the rest of the publisher’s description (20 more lines)
This has had an impact on (i) quality, by reducing missed diagnostics, (ii) efficiency, by reducing turn around time and (iii) capacity, by allowing qualified clinicians to interpret studies with the help of AI.
Comprehensive Chest X-ray: Annalise AI looks for 124 findings + Tuberculosis on Chest X-ray. These findings can be used in various settings including:
- Screening for: (a) TB (b) Pulmonary diseases (COPD, Silicosis) (c) Lung Cancer Screening (d) Heart Failure
- Inpatient setting: (a) Lines and Tubes, (b) Sepsis
- Emergency: (a) Fractures, (b) Pneumothorax etc.
Comprehensive Non-Contrast CT Brain: Annalise AI looks for 130 findings on CT Brain. These findings can be used in various settings including.
- Emergency: ICH, Stroke, Skull Fracture
- Screening for: Atrophy, Brain Tumour etc.
- Inpatient setting: continued monitoring for patients with Surgery etc.
Annalise.ai can be used in several settings:
- Triage cases for immediate review
- Assist radiologists by (a) making them more efficient, and more (b) accurate.
- Write a preliminary report for review and sign off by a radiologist.
Workflow integration:
- Annalise.ai results can be integrated with existing PACS, RIS and EMR systems or viewed on Annalsie.ai Web based viewer.
Clinical validation:
- Our CXR and CTB products have been validated extensively and we have more than 40 publications in various global journals.
- Our products perform very well in all settings including in India
Annalise Enterprise is classified as a Software as a Medical Device and hence would requires regulatory approvals. Annalise is approved for sale in 40+ countries but the product may vary according to the regulations applicable in each market. Please contact us for further information.
For more information visit us at: www.annalise.ai
Preview
3 images
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Sources
Publisher resources
9 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.